by qfrsolutions | Oct 29, 2015 | News
Source: The United States Department of Justice Department of Justice Office of Public Affairs FOR IMMEDIATE RELEASE Thursday, October 29, 2015 Former President and Three District Managers Also Face Criminal Charges Warner Chilcott U.S. Sales LLC, a subsidiary...
by qfrsolutions | Oct 22, 2015 | News
Source: Valeant has faced its fair share of questions from lawmakers, prosecutors and presidential candidates over the past several weeks–and now, it’s facing a whole lot more from investors. The company’s stock tanked by nearly 40% on Wednesday on a...
by qfrsolutions | Oct 14, 2015 | News
Source: The job-cutting ax has been hovering over Kythera Biopharmaceuticals ever since Allergan ($AGN) agreed to buy the company in April. Now, that ax is getting ready to fall. According to a notice filed with the state of California, Kythera will lay off 117...
by qfrsolutions | Oct 8, 2015 | News
Source: California wants to cap drug prices, but Big Pharma isn’t having it. Amid a growing backlash over drug pricing, companies such as Johnson & Johnson ($JNJ) and Bristol-Myers Squibb ($BMY) are funneling millions of dollars into stamping out a new...
by qfrsolutions | Oct 1, 2015 | News
Source: FierceBiotech Tiny OTC-traded micro-cap Avita Medical ($AVMXY) has won backing from the U.S. Biomedical Advanced Research and Development Authority (BARDA) of its PMA approval trial for its ReCell burn treatment device. It will get $16.9 million upfront for...
